{{Rsnum
|rsid=6900796
|Gene=TRMT11
|Chromosome=6
|position=126041008
|Orientation=plus
|GMAF=0.2847
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 28.3 | 45.1 | 26.5
| HCB | 91.8 | 8.2 | 0.0
| JPT | 93.7 | 6.3 | 0.0
| YRI | 69.9 | 27.4 | 2.7
| ASW | 50.9 | 43.9 | 5.3
| CHB | 91.8 | 8.2 | 0.0
| CHD | 92.7 | 7.3 | 0.0
| GIH | 32.7 | 50.0 | 17.3
| LWK | 67.0 | 27.5 | 5.5
| MEX | 51.8 | 32.1 | 16.1
| MKK | 48.1 | 40.3 | 11.7
| TSI | 18.0 | 52.0 | 30.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22386179
|Title=Germline predictors of androgen deprivation therapy response in advanced prostate cancer
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}